Emergence of resistance to tyrosine kinase inhibitors in non-small-cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib.
about
Heat shock protein antagonists in early stage clinical trials for NSCLC.Molecular mechanisms of therapy resistance in solid tumors: chasing "moving" targets.Anaplastic lymphoma kinase rearrangements in non-small-cell lung cancer: novel applications in diagnostics and treatment.MIR21 drives resistance to Heat Shock Protein 90 inhibition in cholangiocarcinoma.Exploiting vulnerabilities in cancer signalling networks to combat targeted therapy resistance
P2860
Emergence of resistance to tyrosine kinase inhibitors in non-small-cell lung cancer can be delayed by an upfront combination with the HSP90 inhibitor onalespib.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Emergence of resistance to tyr ...... the HSP90 inhibitor onalespib.
@en
type
label
Emergence of resistance to tyr ...... the HSP90 inhibitor onalespib.
@en
prefLabel
Emergence of resistance to tyr ...... the HSP90 inhibitor onalespib.
@en
P2093
P2860
P356
P1476
Emergence of resistance to tyr ...... the HSP90 inhibitor onalespib.
@en
P2093
Aurelie Courtin
Harpreet K Saini
John F Lyons
Keisha Hearn
Neil T Thompson
Nicola G Wallis
Tomoko Smyth
P2860
P2888
P304
P356
10.1038/BJC.2016.294
P407
P577
2016-09-27T00:00:00Z
P6179
1031328539